« What Should Non-Chemists Know About Medicinal Chemistry, Anyway? |
| A Database of Side Effects »
January 20, 2010
Honesty, Of A Sort
Chris Viehbacher, CEO of Sanofi-Aventis, gave a speech out at the recent J. P. Morgan healthcare fiesta in San Francisco. He spoke about how nasty the last ten years have been for the industry, calling it a "lost decade", but one particular item really caught my eye (emphasis mine):
". . .for the most part people have zero expectations of Sanofi-Aventis research and development,” he said. “We’ve basically cleared out a lot of bad news, and if anything comes along it should be good news.”
Well, that's one way to do it. I wonder if the performance reviews and yearly goal-setting forms over there read the same way?
+ TrackBacks (0) | Category: Business and Markets
POST A COMMENT
- RELATED ENTRIES
- Merck, Cubist, and Hospira: The Inside
- Another Alzheimer's Antibody Goes Down
- Nativis In the Clinic
- What Would You Put In a Med-Chem Textbook?
- Actavis and Namenda
- J. Already Known Chem.
- Science Gifts 2014: Experiments at Home
- Best and Worst Biotech CEO Time